These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 10407542)

  • 21. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
    Grimm W; Christ M; Bach J; Müller HH; Maisch B
    Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sudden death and hypertrophic cardiomyopathy: a review.
    Ly HQ; Greiss I; Talakic M; Guerra PG; Macle L; Thibault B; Dubuc M; Roy D
    Can J Cardiol; 2005 Apr; 21(5):441-8. PubMed ID: 15861263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathology of sudden cardiac death in patients with ischemic heart disease--arrhythmology for anatomic pathologists.
    Saffitz JE
    Cardiovasc Pathol; 2005; 14(4):195-203. PubMed ID: 16009318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac arrhythmias in congestive heart failure.
    Kantharia BK
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):137-40. PubMed ID: 20136597
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiac magnetic resonance for risk stratification: the sudden death risk portrayed.
    Villuendas R; Kadish AH
    Prog Cardiovasc Dis; 2008; 51(2):128-34. PubMed ID: 18774012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Arrhythmia and sudden cardiac death].
    Sugishita Y; Yamaguchi I
    Nihon Rinsho; 1991 Nov; 49(11):2672-9. PubMed ID: 1770606
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of cardiac arrhythmia among athletes.
    Carro A
    Am J Med; 2011 Aug; 124(8):e13; author reply e15. PubMed ID: 21722861
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M; Di Lenarda A; Proclemer A; Faganello G; Facchin D; Petz E; Sinagra G
    Europace; 2004 Sep; 6(5):400-6. PubMed ID: 15294264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unresolved issues in implantable cardioverter-defibrillator therapy.
    Mason PK; DiMarco JP
    Cardiol Clin; 2008 Aug; 26(3):433-9, vii. PubMed ID: 18538189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sudden cardiac death: history, aetiology and management.
    Mudawi TO; Albouaini K; Kaye GC
    Br J Hosp Med (Lond); 2009 Feb; 70(2):89-94. PubMed ID: 19229149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive arrhythmia risk assessment in guiding pharmacologic therapy for prevention of sudden cardiac death: where do we stand? Where do we go?
    Verrier RL; Josephson ME
    J Cardiovasc Pharmacol; 2010 May; 55(5):425-7. PubMed ID: 20224430
    [No Abstract]   [Full Text] [Related]  

  • 32. Primary prophylaxis of sudden death in hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and dilated cardiomyopathy.
    Klein GJ; Krahn AD; Skanes AC; Yee R; Gula LJ
    J Cardiovasc Electrophysiol; 2005 Sep; 16 Suppl 1():S28-34. PubMed ID: 16138882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sudden cardiac death].
    Stoupel E; Jottrand M
    Rev Med Brux; 2001 Dec; 22(6):488-96. PubMed ID: 11811044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of sudden cardiac death: a current perspective.
    Domanski MJ; Exner DV
    J Electrocardiol; 1998; 31 Suppl():47-53. PubMed ID: 9988005
    [No Abstract]   [Full Text] [Related]  

  • 35. [Primary prevention of sudden cardiac death].
    Burkhard-Meier C; Hoppe UC
    Dtsch Med Wochenschr; 2003 Nov; 128(48):2547-52. PubMed ID: 14648439
    [No Abstract]   [Full Text] [Related]  

  • 36. Identify the young athlete at risk for sudden cardiac death.
    Lipp LN
    JAAPA; 2001 Aug; 14(8):26-8, 31-2, 35-7. PubMed ID: 11556060
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
    Klein MH; Gold MR
    Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.
    Adabag AS; Maron BJ
    Ann Noninvasive Electrocardiol; 2007 Apr; 12(2):171-80. PubMed ID: 17593187
    [No Abstract]   [Full Text] [Related]  

  • 39. Secondary prevention of sudden cardiac death.
    Curnis A; Mascioli G; Bontempi L; Bordonali T; Dei Cas L
    Ital Heart J; 2005 Mar; 6(3):216-20. PubMed ID: 15875512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Sudden death: from epidemiology to therapeutic management-prevention].
    Aliot E
    Arch Mal Coeur Vaiss; 2000 Jun; Spec No():27-9. PubMed ID: 10949712
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.